<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3d61-56a7-013e-6696af6e477f</uuid><title>Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients</title><shortTitle>Prostate_Cancer</shortTitle><emeasureid>129</emeasureid><finalizedDate>05/10/2013 03:52 PM</finalizedDate><guid>1635c14d-e612-4fa6-96cd-285361aa7f7b</guid><version>3</version><status>In Progress</status><nqfid extension="0389" root="2.16.840.1.113883.3.560.1"/><period uuid="89971141-1817-46cd-a850-cb75f5a023a3"><startDate uuid="e6429a12-6fed-4ddd-a714-b9909546b677">00000101</startDate><stopDate uuid="bd7b2632-c8a4-47df-bd91-9effec71f206">00001231</stopDate></period><steward id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</steward><developers><developer id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer</description><copyright>Copyright 2012 American Medical Association. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (PCPI[R]). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI). Neither the AMA, PCPI nor its members shall be responsible for any use of the Measures. 

THE MEASURES AND SPECIFICATIONS ARE PROVIDED ?AS IS? WITHOUT WARRANTY OF ANY KIND. 

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. 

CPT(R) contained in the Measure specifications is copyright 2004-2012 American Medical Association. LOINC(R) copyright 2004-2012 Regenstrief Institute, Inc. 

This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2012 International Health Terminology Standards Development Organisation. ICD-10 copyright 2012 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>A bone scan is generally not required for staging prostate cancer in men with a low risk of recurrence and receiving primary therapy. This measure is written as a negative measure so that the performance goal is 100%, consistent with the other measures for this condition.</rationale><recommendations>Routine use of a bone scan is not required for staging asymptomatic men with clinically localized prostate cancer when their PSA is equal to or less than 20.0 ng/mL. (AUA, 2009)

For symptomatic patients and/or those with a life expectancy of greater than 5 years, a bone scan is appropriate for patients with any of the following: 1) T1 disease with PSA over 20 ng/mL or T2 disease with PSA over 10 ng/mL; 2) a Gleason score of 8 or higher; 3) T3 to T4 tumors or symptomatic disease. (NCCN, 2011) (Category 2A)</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>American Urological Association (AUA). Guideline for the Management of Clinically Localized Prostate Cancer: 2007 update. J Urol. 2007;177:2106-2131.</reference><reference>Prostate-Specific Antigen Best Practice Statement: 2009 Update from American Urological Association, American Urological Association Education and Research, Inc. Available at: http://www.auanet.org/content/guidelines-and-qualitycare/clinical-guidelines/main-reports/psa09.pdf</reference><reference>National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 4.2011. Available at www.nccn.org</reference></references><definitions>Risk Strata Definitions: Low, Intermediate, or High ?
Low Risk ? PSA &lt;= 10 ng/mL; AND Gleason score 6 or less; AND clinical stage T1c or T2a. (AUA, 2007)
Intermediate Risk ? PSA &gt; 10 to 20 ng/mL; OR Gleason score 7; OR clinical stage T2b, and not qualifying for high risk. (AUA, 2007)
High Risk ? PSA &gt; 20 ng/mL; OR Gleason score 8 to 10; OR clinically localized stage T3a. (NCCN, 2011)</definitions><guidance>A higher score indicates appropriate treatment of patients with prostate cancer at low risk of recurrence.
Only patients with prostate cancer with low risk of recurrence will be counted in the performance denominator of this measure.</guidance><transmissionFormat>TBD</transmissionFormat><initialPatientPopDescription>All patients, regardless of age, with a diagnosis of prostate cancer</initialPatientPopDescription><denominatorDescription>Equals Initial Patient Population at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician)</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="4bd78ccf-01fc-41d0-82c7-fc5dc0f2916c">None</qualityMeasureSet></measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-6696af844783" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-6696af844784" name="Race"/><elementRef id="40280381-3d61-56a7-013e-6696af844785" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-6696af844786" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="0C93BCFB-FC6E-4CE4-8EAA-F80F3B7AF5A9"><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Prostate Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af844787" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6696af854789" type="qdm"/></relationalOp><elementRef displayName="Male : Patient Characteristic Sex" id="40280381-3d61-56a7-013e-6696af854788" type="qdm"/><functionalOp displayName="NOT" type="NOT" uuid="93786744-6ebc-4ac8-b356-5477e5b2bfa5"><relationalOp displayName="Ends Before Start Of" type="EBS"><elementRef displayName="Occurrence A of Prostate Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af844787" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6696af854789" type="qdm"/></relationalOp></functionalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="54CC77B3-0163-45ED-A818-88D6F08E4DB9"><logicalOp displayName="AND" type="and"><functionalOp displayName="FIRST" type="FIRST" uuid="8c3eb9dc-98ff-48be-9ae7-0cba07adf40d"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Prostate Cancer Treatment : Procedure, Performed" id="40280381-3d61-56a7-013e-6696af85478a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6696af854789" type="qdm"/></relationalOp></functionalOp><logicalOp displayName="AND" type="and"><logicalOp displayName="AND" type="and"><functionalOp displayName="MOST RECENT" type="MOST RECENT" uuid="6ff3303c-d15d-4bae-8284-7c8ed43dcfcc"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence A of Prostate Specific Antigen Test : Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844780" type="qdm"/><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6696af844781" type="qdm"/></relationalOp></functionalOp><elementRef displayName="Occurrence A of Prostate Specific Antigen Test : Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844780" type="qdm"><attribute comparisonValue="10" mode="Less Than or Equal To" name="result" unit="ng/dL"/></elementRef></logicalOp><logicalOp displayName="AND" type="and"><functionalOp displayName="MOST RECENT" type="MOST RECENT" uuid="68e3bd71-9746-4ed7-90d2-d1daafc67989"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence A of Gleason Score : Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844782" type="qdm"/><elementRef displayName="Occurrence A of Prostate Cancer Treatment : Procedure, Performed" id="40280381-3d61-56a7-013e-6696af85478a" type="qdm"/></relationalOp></functionalOp><elementRef displayName="Occurrence A of Gleason Score : Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844782" type="qdm"><attribute comparisonValue="6" mode="Less Than or Equal To" name="result" unit=""/></elementRef></logicalOp><logicalOp displayName="AND" type="and"><functionalOp displayName="MOST RECENT" type="MOST RECENT" uuid="4f488acb-91b0-4fa0-93a2-45b01eba2044"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6696af844781" type="qdm"/><elementRef displayName="Occurrence A of Prostate Cancer Treatment : Procedure, Performed" id="40280381-3d61-56a7-013e-6696af85478a" type="qdm"/></relationalOp></functionalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6696af844781" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6696af85478b"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6696af844781" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6696af85478c"/></elementRef></logicalOp></logicalOp></logicalOp></logicalOp></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="65F6E3C8-8DC4-4B59-9869-A5103ABB832D"><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="OR" type="or"><elementRef displayName="Pain Related to Prostate Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af854791" type="qdm"/><elementRef displayName="Salvage Therapy : Procedure, Performed" id="40280381-3d61-56a7-013e-6696af854792" type="qdm"/><elementRef displayName="Bone Scan : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-6696af854790" type="qdm"><attribute mode="Value Set" name="reason" qdmUUID="40280381-3d61-56a7-013e-6696af854795"/></elementRef></logicalOp><elementRef displayName="Occurrence A of Prostate Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af844787" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="626035B4-2903-462F-AB07-561F195DB22A"><logicalOp displayName="AND" type="and"><functionalOp displayName="NOT" type="NOT" uuid="dab54049-df45-4249-b5e4-cdb9d667f92b"><relationalOp displayName="Starts After Start Of" type="SAS"><elementRef displayName="Bone Scan : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-6696af854790" type="qdm"/><elementRef displayName="Occurrence A of Prostate Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af844787" type="qdm"/></relationalOp></functionalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844780" instance="Occurrence A" name="Prostate Specific Antigen Test" oid="2.16.840.1.113883.3.526.3.401" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af844780" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Procedure, Result" id="40280381-3d61-56a7-013e-6696af844781" instance="Occurrence A" name="Clinical Staging Procedure" oid="2.16.840.1.113883.3.526.3.1098" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af844781" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Laboratory Test, Result" id="40280381-3d61-56a7-013e-6696af844782" instance="Occurrence A" name="Gleason Score" oid="2.16.840.1.113883.3.526.3.397" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af844782" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-6696af844783" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="Administrative Sex" uuid="40280381-3d61-56a7-013e-6696af844783" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-6696af844784" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-6696af844784" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-6696af844785" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-6696af844785" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-6696af844786" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="Source of Payment Typology" uuid="40280381-3d61-56a7-013e-6696af844786" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af844787" instance="Occurrence A" name="Prostate Cancer" oid="2.16.840.1.113883.3.526.3.319" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af844787" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-6696af854788" name="Male" oid="2.16.840.1.113883.3.560.100.1" suppDataElement="false" taxonomy="Administrative Sex" uuid="40280381-3d61-56a7-013e-6696af854788" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-6696af854789" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-6696af854789" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Procedure, Performed" id="40280381-3d61-56a7-013e-6696af85478a" instance="Occurrence A" name="Prostate Cancer Treatment" oid="2.16.840.1.113883.3.526.3.398" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af85478a" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6696af85478b" name="Prostate Cancer Primary Tumor Size T1c" oid="2.16.840.1.113883.3.526.3.1325" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af85478b" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6696af85478c" name="Prostate Cancer Primary Tumor Size T2a" oid="2.16.840.1.113883.3.526.3.1326" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af85478c" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-6696af854790" name="Bone Scan" oid="2.16.840.1.113883.3.526.3.320" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af854790" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6696af854791" name="Pain Related to Prostate Cancer" oid="2.16.840.1.113883.3.526.3.451" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af854791" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Procedure, Performed" id="40280381-3d61-56a7-013e-6696af854792" name="Salvage Therapy" oid="2.16.840.1.113883.3.526.3.399" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af854792" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6696af854795" name="Reason Documented" oid="2.16.840.1.113883.3.526.3.1494" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6696af854795" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3d61-56a7-013e-6696dd0c47dd"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
